Product Program year 2025 Source: CMS Open Payments

Triptodur

Drug Endocrinology

NDC 24338-150-20

Open in the dashboard

General payments

$52,236

1,386 payments

Research payments

$0

0 payments

Through program year 2025, $52,236 in general payments and $0 in research payments were reported against Triptodur (Endocrinology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $29,171 709
2024 General $23,065 677

Breakdown

Who paid General payments · program years 2024–2025
  1. CutisPharma, Inc. $52,236 1,386 payments
Top recipients General payments · program year 2025
  1. Joshua Yang Pediatric Endocrinology · Orlando, FL $6,058 21% · 14 payments
  2. Quentin Vanmeter Pediatric Endocrinology · Atlanta, GA $4,517 15% · 17 payments
  3. Lisa Knight Pediatric Endocrinology · Columbia, SC $1,350 5% · 1 payment
  4. Jose Gamez-Godoy Pediatric Endocrinology · Edinburg, TX $810 3% · 2 payments
  5. Jessica Aguilar Nurse Practitioner, Primary Care · Los Angeles, CA $175 <1% · 11 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Endocrinology Pediatrics $19,629 68% · 146 practitioners
  2. Nurse Practitioner, Pediatrics Nurse Practitioner $1,883 7% · 39 practitioners
  3. Pediatrics $1,554 5% · 43 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $1,018 4% · 24 practitioners
  5. Nurse Practitioner $846 3% · 20 practitioners

The top 5 of 46 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $9,387 32% · 68 recipients
  2. Georgia $5,090 17% · 15 recipients
  3. California $2,873 10% · 72 recipients
  4. Texas $1,953 7% · 22 recipients
  5. New York $1,882 6% · 53 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,386 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record